首页 > 最新文献

世界危重病急救学杂志(英文版)最新文献

英文 中文
Septic shock 3.0 criteria application in severe COVID-19 patients: An unattended sepsis population with high mortality risk. 脓毒症休克3.0标准在重症COVID-19患者中的应用:一个高死亡风险的无人护理脓毒症人群
Pub Date : 2022-07-09 DOI: 10.5492/wjccm.v11.i4.246
José Pedro Cidade, L M Coelho, Vasco Costa, Rui Morais, Patrícia Moniz, Luís Morais, Pedro Fidalgo, António Tralhão, Carolina Paulino, David Nora, Bernardino Valério, Vítor Mendes, Camila Tapadinhas, Pedro Povoa

Background: Coronavirus disease 2019 (COVID-19) can be associated with life-threatening organ dysfunction due to septic shock, frequently requiring intensive care unit (ICU) admission, respiratory and vasopressor support. Therefore, clear clinical criteria are pivotal for early recognition of patients more likely to need prompt organ support. Although most patients with severe COVID-19 meet the Sepsis-3.0 criteria for septic shock, it has been increasingly recognized that hyperlactatemia is frequently absent, possibly leading to an underestimation of illness severity and mortality risk.

Aim: To identify the proportion of severe COVID-19 patients with vasopressor support requirements, with and without hyperlactatemia, and describe their clinical outcomes and mortality.

Methods: We performed a single-center prospective cohort study. All adult patients admitted to the ICU with COVID-19 were included in the analysis and were further divided into three groups: Sepsis group, without both criteria; Vasoplegic Shock group, with persistent hypotension and vasopressor support without hyperlactatemia; and Septic Shock 3.0 group, with both criteria. COVID-19 was diagnosed using clinical and radiologic criteria with a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive RT-PCR test.

Results: 118 patients (mean age 63 years, 87% males) were included in the analysis (n = 51 Sepsis group, n = 26 Vasoplegic Shock group, and n = 41 Septic Shock 3.0 group). SOFA score at ICU admission and ICU length of stay were different between the groups (P < 0.001). Mortality was significantly higher in the Vasoplegic Shock and Septic Shock 3.0 groups when compared with the Sepsis group (P < 0.001) without a significant difference between the former two groups (P = 0.713). The log rank tests of Kaplan-Meier survival curves were also different (P = 0.007). Ventilator-free days and vasopressor-free days were different between the Sepsis vs Vasoplegic Shock and Septic Shock 3.0 groups (both P < 0.001), and similar in the last two groups (P = 0.128 and P = 0.133, respectively). Logistic regression identified the maximum dose of vasopressor therapy used (AOR 1.046; 95%CI: 1.012-1.082, P = 0.008) and serum lactate level (AOR 1.542; 95%CI: 1.055-2.255, P = 0.02) as the major explanatory variables of mortality rates (R 2 0.79).

Conclusion: In severe COVID-19 patients, the Sepsis 3.0 criteria of septic shock may exclude approximately one third of patients with a similarly high risk of a poor outcome and mortality rate, which should be equally addressed.

背景:2019冠状病毒病(COVID-19)可能与感染性休克引起的危及生命的器官功能障碍有关,经常需要重症监护病房(ICU)住院,并提供呼吸和血管加压药物支持。因此,明确的临床标准对于早期识别更可能需要及时器官支持的患者至关重要。尽管大多数重症COVID-19患者符合脓毒症-3.0的脓毒症休克标准,但越来越多的人认识到,高乳酸血症往往不存在,这可能导致低估疾病严重程度和死亡风险。目的:了解合并和不合并高乳酸血症的重症COVID-19患者有血管加压素支持需求的比例,并描述其临床结局和死亡率。方法:我们进行了一项单中心前瞻性队列研究。所有入住ICU的COVID-19成年患者纳入分析,并进一步分为三组:脓毒症组,没有两个标准;血管截瘫休克组,伴持续性低血压和血管加压药物支持,无高乳酸血症;感染性休克3.0组,两种标准均符合。采用严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) RT-PCR阳性的临床和放射学标准诊断COVID-19。结果:纳入118例患者,平均年龄63岁,男性87%,其中脓毒症组51例,血管截瘫休克组26例,脓毒症休克3.0组41例。两组患者入院时SOFA评分及ICU住院时间差异有统计学意义(P < 0.001)。与脓毒症组相比,血管截瘫性休克和脓毒症休克3.0组的死亡率显著升高(P < 0.001),两组间差异无统计学意义(P = 0.713)。Kaplan-Meier生存曲线的对数秩检验也有差异(P = 0.007)。脓毒症vs血管性休克和脓毒症休克3.0组无呼吸机天数和无血管加压剂天数差异有统计学意义(P < 0.001),后两组无呼吸机天数相似(P = 0.128和P = 0.133)。Logistic回归确定了使用血管加压剂治疗的最大剂量(AOR 1.046;95%CI: 1.012-1.082, P = 0.008)和血清乳酸水平(AOR 1.542;95%CI: 1.055 ~ 2.255, P = 0.02)为死亡率的主要解释变量(R = 0.79)。结论:在重症COVID-19患者中,脓毒症3.0标准可能会排除大约三分之一具有类似不良结局和死亡率高风险的患者,应平等对待。
{"title":"Septic shock 3.0 criteria application in severe COVID-19 patients: An unattended sepsis population with high mortality risk.","authors":"José Pedro Cidade,&nbsp;L M Coelho,&nbsp;Vasco Costa,&nbsp;Rui Morais,&nbsp;Patrícia Moniz,&nbsp;Luís Morais,&nbsp;Pedro Fidalgo,&nbsp;António Tralhão,&nbsp;Carolina Paulino,&nbsp;David Nora,&nbsp;Bernardino Valério,&nbsp;Vítor Mendes,&nbsp;Camila Tapadinhas,&nbsp;Pedro Povoa","doi":"10.5492/wjccm.v11.i4.246","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i4.246","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19) can be associated with life-threatening organ dysfunction due to septic shock, frequently requiring intensive care unit (ICU) admission, respiratory and vasopressor support. Therefore, clear clinical criteria are pivotal for early recognition of patients more likely to need prompt organ support. Although most patients with severe COVID-19 meet the Sepsis-3.0 criteria for septic shock, it has been increasingly recognized that hyperlactatemia is frequently absent, possibly leading to an underestimation of illness severity and mortality risk.</p><p><strong>Aim: </strong>To identify the proportion of severe COVID-19 patients with vasopressor support requirements, with and without hyperlactatemia, and describe their clinical outcomes and mortality.</p><p><strong>Methods: </strong>We performed a single-center prospective cohort study. All adult patients admitted to the ICU with COVID-19 were included in the analysis and were further divided into three groups: Sepsis group, without both criteria; Vasoplegic Shock group, with persistent hypotension and vasopressor support without hyperlactatemia; and Septic Shock 3.0 group, with both criteria. COVID-19 was diagnosed using clinical and radiologic criteria with a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive RT-PCR test.</p><p><strong>Results: </strong>118 patients (mean age 63 years, 87% males) were included in the analysis (<i>n</i> = 51 Sepsis group, <i>n</i> = 26 Vasoplegic Shock group, and <i>n</i> = 41 Septic Shock 3.0 group). SOFA score at ICU admission and ICU length of stay were different between the groups (<i>P</i> < 0.001). Mortality was significantly higher in the Vasoplegic Shock and Septic Shock 3.0 groups when compared with the Sepsis group (<i>P</i> < 0.001) without a significant difference between the former two groups (<i>P</i> = 0.713). The log rank tests of Kaplan-Meier survival curves were also different (<i>P</i> = 0.007). Ventilator-free days and vasopressor-free days were different between the Sepsis <i>vs</i> Vasoplegic Shock and Septic Shock 3.0 groups (both <i>P</i> < 0.001), and similar in the last two groups (<i>P</i> = 0.128 and <i>P</i> = 0.133, respectively). Logistic regression identified the maximum dose of vasopressor therapy used (AOR 1.046; 95%CI: 1.012-1.082, <i>P</i> = 0.008) and serum lactate level (AOR 1.542; 95%CI: 1.055-2.255, <i>P</i> = 0.02) as the major explanatory variables of mortality rates (<i>R</i> <sup>2</sup> 0.79).</p><p><strong>Conclusion: </strong>In severe COVID-19 patients, the Sepsis 3.0 criteria of septic shock may exclude approximately one third of patients with a similarly high risk of a poor outcome and mortality rate, which should be equally addressed.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/09/f1/WJCCM-11-246.PMC9305684.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40343617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Cough as a neurological sign: What a clinician should know. 咳嗽作为一种神经症状:临床医生应该知道的。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.115
Mohammed Al-Biltagi, Adel Salah Bediwy, Nermin Kamal Saeed

Cough is a common respiratory complaint driving patients to seek medical advice. Besides being a fundamental respiratory sign, it is also a crucial neurological sign. There are three main types of coughs: Reflex cough (type I), voluntary cough (type II), and evoked cough (type III). Cough is a reflex predominantly mediated by control centers in the respiratory areas of the brainstem, modulated by the cerebral cortex. Cough reflex sensitivity could be increased in many neurological disorders such as brainstem space-occupying lesions, medullary lesions secondary to Chiari type I malformations, tics disorders such as Tourette's syndrome, somatic cough, cerebellar neurodegenerative diseases, and chronic vagal neuropathy due to allergic and non-allergic conditions. Meanwhile, cough sensitivity decreases in multiple sclerosis, brain hypoxia, cerebral hemispheric stroke with a brainstem shock, Parkinson's disease, dementia due to Lewy body disease, amyotrophic lateral sclerosis, and peripheral neuropathy as diabetic neuropathy, hereditary sensory and autonomic neuropathy type IV, vitamin B12, and folate deficiency. Arnold's nerve ear-cough reflex, syncopal cough, cough headache, opioids-associated cough, and cough-anal reflex are signs that could help diagnose underlying neurological conditions. Cough reflex testing is a quick, easy, and cheap test performed during the cranial nerve examination. In this article, we reviewed the role of cough in various neurological disorders that increase or decrease cough sensitivity.

咳嗽是一种常见的呼吸系统疾病,促使患者寻求医疗建议。它不仅是一种基本的呼吸体征,也是一种至关重要的神经体征。咳嗽主要有三种类型:反射性咳嗽(I型)、自发性咳嗽(II型)和诱发性咳嗽(III型)。咳嗽是一种反射性咳嗽,主要由脑干呼吸区控制中心介导,受大脑皮层调节。咳嗽反射敏感性可能在许多神经系统疾病中增加,如脑干占位病变、继发于Chiari I型畸形的髓质病变、抽动障碍(如图雷特综合征)、躯体咳嗽、小脑神经退行性疾病和由过敏和非过敏条件引起的慢性迷走神经病变。同时,多发性硬化症、脑缺氧、脑半球卒中伴脑干休克、帕金森病、路易体痴呆、肌萎缩性侧索硬化症、周围神经病变如糖尿病神经病变、遗传性感觉和自主神经病变IV型、维生素B12和叶酸缺乏症的咳嗽敏感性降低。阿诺德神经耳咳反射、晕厥咳嗽、咳嗽头痛、阿片类药物相关的咳嗽和咳嗽肛门反射都是有助于诊断潜在神经系统疾病的迹象。咳嗽反射测试是在脑神经检查中进行的一种快速、简单、廉价的测试。在本文中,我们回顾了咳嗽在各种神经系统疾病中增加或减少咳嗽敏感性的作用。
{"title":"Cough as a neurological sign: What a clinician should know.","authors":"Mohammed Al-Biltagi,&nbsp;Adel Salah Bediwy,&nbsp;Nermin Kamal Saeed","doi":"10.5492/wjccm.v11.i3.115","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.115","url":null,"abstract":"<p><p>Cough is a common respiratory complaint driving patients to seek medical advice. Besides being a fundamental respiratory sign, it is also a crucial neurological sign. There are three main types of coughs: Reflex cough (type I), voluntary cough (type II), and evoked cough (type III). Cough is a reflex predominantly mediated by control centers in the respiratory areas of the brainstem, modulated by the cerebral cortex. Cough reflex sensitivity could be increased in many neurological disorders such as brainstem space-occupying lesions, medullary lesions secondary to Chiari type I malformations, tics disorders such as Tourette's syndrome, somatic cough, cerebellar neurodegenerative diseases, and chronic vagal neuropathy due to allergic and non-allergic conditions. Meanwhile, cough sensitivity decreases in multiple sclerosis, brain hypoxia, cerebral hemispheric stroke with a brainstem shock, Parkinson's disease, dementia due to Lewy body disease, amyotrophic lateral sclerosis, and peripheral neuropathy as diabetic neuropathy, hereditary sensory and autonomic neuropathy type IV, vitamin B12, and folate deficiency. Arnold's nerve ear-cough reflex, syncopal cough, cough headache, opioids-associated cough, and cough-anal reflex are signs that could help diagnose underlying neurological conditions. Cough reflex testing is a quick, easy, and cheap test performed during the cranial nerve examination. In this article, we reviewed the role of cough in various neurological disorders that increase or decrease cough sensitivity.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/d8/WJCCM-11-115.PMC9136724.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Presentation and outcome of myocardial infarction with non-obstructive coronary arteries in coronavirus disease 2019. 2019年冠状病毒病冠状动脉非阻塞性心肌梗死的表现和预后。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.129
Kevin John, Amos Lal, Nitish Sharma, Amr ElMeligy, Ajay K Mishra

Among the cardiac complications of coronavirus disease 2019 (COVID-19), one increasingly reported in the literature is myocardial infarction with non-obstructive coronaries (MINOCA). We reviewed all reported cases of MINOCA in COVID-19 patients to summarize its clinical features, evaluation, and treatment. We performed a literature search in Pubmed using the search terms 'COVID-19' and 'MINOCA' or 'non-obstructive coronaries'. Among the reported cases, the mean age was 61.5 years (SD ± 13.4), and 50% were men. Chest pain was the presenting symptom in five patients (62.5%), and hypertension was the most common comorbidity (62.5%). ST-elevation was seen in most patients (87.5%), and the overall mortality rate was 37.5%. MINOCA in COVID-19 is an entity with a broad differential diagnosis. Therefore, a uniform algorithm is needed in its evaluation to ensure timely diagnosis and management.

在冠状病毒病 2019(COVID-19)的心脏并发症中,文献中报道较多的一种是冠状动脉非阻塞性心肌梗死(MINOCA)。我们回顾了所有报道的 COVID-19 患者 MINOCA 病例,总结了其临床特征、评估和治疗方法。我们以 "COVID-19 "和 "MINOCA "或 "非阻塞性冠状动脉 "为检索词在 Pubmed 上进行了文献检索。在报告的病例中,平均年龄为 61.5 岁(SD ± 13.4),50% 为男性。胸痛是五名患者(62.5%)的主要症状,高血压是最常见的合并症(62.5%)。大多数患者(87.5%)出现 ST 段抬高,总死亡率为 37.5%。COVID-19中的MINOCA是一种具有广泛鉴别诊断的疾病。因此,需要对其进行统一的评估,以确保及时诊断和处理。
{"title":"Presentation and outcome of myocardial infarction with non-obstructive coronary arteries in coronavirus disease 2019.","authors":"Kevin John, Amos Lal, Nitish Sharma, Amr ElMeligy, Ajay K Mishra","doi":"10.5492/wjccm.v11.i3.129","DOIUrl":"10.5492/wjccm.v11.i3.129","url":null,"abstract":"<p><p>Among the cardiac complications of coronavirus disease 2019 (COVID-19), one increasingly reported in the literature is myocardial infarction with non-obstructive coronaries (MINOCA). We reviewed all reported cases of MINOCA in COVID-19 patients to summarize its clinical features, evaluation, and treatment. We performed a literature search in Pubmed using the search terms 'COVID-19' and 'MINOCA' or 'non-obstructive coronaries'. Among the reported cases, the mean age was 61.5 years (SD ± 13.4), and 50% were men. Chest pain was the presenting symptom in five patients (62.5%), and hypertension was the most common comorbidity (62.5%). ST-elevation was seen in most patients (87.5%), and the overall mortality rate was 37.5%. MINOCA in COVID-19 is an entity with a broad differential diagnosis. Therefore, a uniform algorithm is needed in its evaluation to ensure timely diagnosis and management.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b5/82/WJCCM-11-129.PMC9136718.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40680835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical care practices in the world: Results of the global intensive care unit need assessment survey 2020. 世界重症监护实践:2020 年全球重症监护病房需求评估调查结果》。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.169
Faisal A Nawaz, Neha Deo, Salim Surani, William Maynard, Martin L Gibbs, Rahul Kashyap

Background: There is variability in intensive care unit (ICU) resources and staffing worldwide. This may reflect variation in practice and outcomes across all health systems.

Aim: To improve research and quality improvement measures administrative leaders can create long-term strategies by understanding the nature of ICU practices on a global scale.

Methods: The Global ICU Needs Assessment Research Group was formed on the basis of diversified skill sets. We aimed to survey sites regarding ICU type, availability of staffing, and adherence to critical care protocols. An international survey 'Global ICU Needs Assessment' was created using Google Forms, and this was distributed from February 17th, 2020 till September 23rd, 2020. The survey was shared with ICU providers in 34 countries. Various approaches to motivating healthcare providers were implemented in securing submissions, including use of emails, phone calls, social media applications, and WhatsApp™. By completing this survey, providers gave their consent for research purposes. This study was deemed eligible for category-2 Institutional Review Board exempt status.

Results: There were a total 121 adult/adult-pediatrics ICU responses from 34 countries in 76 cities. A majority of the ICUs were mixed medical-surgical [92 (76%)]. 108 (89%) were adult-only ICUs. Total 36 respondents (29.8%) were 31-40 years of age, with 79 (65%) male and 41 (35%) female participants. 89 were consultants (74%). A total of 71 (59%) respondents reported having a 24-h in-house intensivist. A total of 87 (72%) ICUs were reported to have either a 2:1 or ≥ 2:1 patient/nurse ratio. About 44% of the ICUs were open and 76% were mixed type (medical-surgical). Protocols followed regularly by the ICUs included sepsis care (82%), ventilator-associated pneumonia (79%); nutrition (76%), deep vein thrombosis prophylaxis (84%), stress ulcer prophylaxis (84%), and glycemic control (89%).

Conclusion: Based on the findings of this international, multi-dimensional, needs-assessment survey, there is a need for increased recruitment and staffing in critical care facilities, along with improved patient-to-nurse ratios. Future research is warranted in this field with focus on implementing appropriate health standards, protocols and resources for optimal efficiency in critical care worldwide.

背景:全球重症监护病房(ICU)的资源和人员配备存在差异。目的:通过了解全球重症监护室的工作性质,行政领导者可以制定长期战略,从而改进研究和质量改进措施:全球重症监护室需求评估研究小组是在多元化技能组合的基础上成立的。我们的目标是调查重症监护室的类型、人员配备情况以及重症监护协议的遵守情况。我们使用谷歌表格创建了 "全球重症监护室需求评估 "国际调查表,并于 2020 年 2 月 17 日至 2020 年 9 月 23 日进行了分发。该调查与 34 个国家的重症监护室提供者分享。在确保提交调查问卷的过程中,我们采用了各种激励医疗服务提供者的方法,包括使用电子邮件、电话、社交媒体应用程序和 WhatsApp™。医疗服务提供者在填写本调查问卷时表示同意将其用于研究目的。这项研究被认为符合机构审查委员会第二类豁免资格:共有来自 34 个国家 76 个城市的 121 个成人/成人-儿科重症监护室回复。大多数重症监护室为内外科混合型[92(76%)]。108所(89%)为成人重症监护病房。共有 36 名受访者(29.8%)的年龄在 31-40 岁之间,其中男性 79 人(65%),女性 41 人(35%)。89 人是顾问(74%)。共有 71 位受访者(59%)表示拥有 24 小时内部重症监护医生。据报告,共有 87 个(72%)重症监护病房的患者/护士比例为 2:1 或≥ 2:1。约 44% 的重症监护室为开放式,76% 为混合型(内外科)。重症监护室定期遵循的协议包括败血症护理(82%)、呼吸机相关肺炎(79%)、营养(76%)、深静脉血栓预防(84%)、应激性溃疡预防(84%)和血糖控制(89%):根据这项国际性、多维度、需求评估调查的结果,重症监护机构需要增加招聘和人员配置,同时改善病人与护士的比例。该领域未来的研究重点是实施适当的健康标准、协议和资源,以在全球范围内实现重症监护的最佳效率。
{"title":"Critical care practices in the world: Results of the global intensive care unit need assessment survey 2020.","authors":"Faisal A Nawaz, Neha Deo, Salim Surani, William Maynard, Martin L Gibbs, Rahul Kashyap","doi":"10.5492/wjccm.v11.i3.169","DOIUrl":"10.5492/wjccm.v11.i3.169","url":null,"abstract":"<p><strong>Background: </strong>There is variability in intensive care unit (ICU) resources and staffing worldwide. This may reflect variation in practice and outcomes across all health systems.</p><p><strong>Aim: </strong>To improve research and quality improvement measures administrative leaders can create long-term strategies by understanding the nature of ICU practices on a global scale.</p><p><strong>Methods: </strong>The Global ICU Needs Assessment Research Group was formed on the basis of diversified skill sets. We aimed to survey sites regarding ICU type, availability of staffing, and adherence to critical care protocols. An international survey 'Global ICU Needs Assessment' was created using Google Forms, and this was distributed from February 17<sup>th</sup>, 2020 till September 23<sup>rd</sup>, 2020. The survey was shared with ICU providers in 34 countries. Various approaches to motivating healthcare providers were implemented in securing submissions, including use of emails, phone calls, social media applications, and WhatsApp™. By completing this survey, providers gave their consent for research purposes. This study was deemed eligible for category-2 Institutional Review Board exempt status.</p><p><strong>Results: </strong>There were a total 121 adult/adult-pediatrics ICU responses from 34 countries in 76 cities. A majority of the ICUs were mixed medical-surgical [92 (76%)]. 108 (89%) were adult-only ICUs. Total 36 respondents (29.8%) were 31-40 years of age, with 79 (65%) male and 41 (35%) female participants. 89 were consultants (74%). A total of 71 (59%) respondents reported having a 24-h in-house intensivist. A total of 87 (72%) ICUs were reported to have either a 2:1 or ≥ 2:1 patient/nurse ratio. About 44% of the ICUs were open and 76% were mixed type (medical-surgical). Protocols followed regularly by the ICUs included sepsis care (82%), ventilator-associated pneumonia (79%); nutrition (76%), deep vein thrombosis prophylaxis (84%), stress ulcer prophylaxis (84%), and glycemic control (89%).</p><p><strong>Conclusion: </strong>Based on the findings of this international, multi-dimensional, needs-assessment survey, there is a need for increased recruitment and staffing in critical care facilities, along with improved patient-to-nurse ratios. Future research is warranted in this field with focus on implementing appropriate health standards, protocols and resources for optimal efficiency in critical care worldwide.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/49/WJCCM-11-169.PMC9136725.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diuretic combinations in critically ill patients with respiratory failure: A systematic review and meta-analysis. 利尿剂联合治疗危重患者呼吸衰竭:系统回顾和荟萃分析。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.178
Jean Maxime Côté, Nadir Goulamhoussen, Blaithin A McMahon, Patrick T Murray

Background: In patients with respiratory failure, loop diuretics remain the cornerstone of the treatment to maintain fluid balance, but resistance is common.

Aim: To determine the efficacy and safety of common diuretic combinations in critically ill patients with respiratory failure.

Methods: We searched MEDLINE, Embase, Cochrane Library and PROSPERO for studies reporting the effects of a combination of a loop diuretic with another class of diuretic. A meta-analysis using mean differences (MD) with 95% confidence interval (CI) was performed for the 24-h fluid balance (primary outcome) and the 24-h urine output, while descriptive statistics were used for safety events.

Results: Nine studies totalling 440 patients from a total of 6510 citations were included. When compared to loop diuretics alone, the addition of a second diuretic is associated with an improved negative fluid balance at 24 h [MD: -1.06 L (95%CI: -1.46; -0.65)], driven by the combination of a thiazide plus furosemide [MD: -1.25 L (95%CI: -1.68; -0.82)], while no difference was observed with the combination of a loop-diuretic plus acetazolamide [MD: -0.40 L (95%CI: -0.96; 0.16)] or spironolactone [MD: -0.65 L (95%CI: -1.66; 0.36)]. Heterogeneity was high and the report of clinical and safety endpoints varied across studies.

Conclusion: Based on limited evidence, the addition of a second diuretic to a loop diuretic may promote diuresis and negative fluid balance in patients with respiratory failure, but only when using a thiazide. Further larger trials to evaluate the safety and efficacy of such interventions in patients with respiratory failure are required.

背景:在呼吸衰竭患者中,循环利尿剂仍然是维持体液平衡治疗的基础,但抵抗是常见的。目的:探讨常用利尿剂联合应用对危重呼吸衰竭患者的疗效和安全性。方法:我们检索了MEDLINE、Embase、Cochrane Library和PROSPERO,以报告一种环状利尿剂与另一种利尿剂联合使用的效果。采用95%可信区间(CI)的平均差异(MD)对24小时体液平衡(主要结局)和24小时尿量进行meta分析,同时对安全事件进行描述性统计。结果:纳入9项研究,共计440例患者,共6510次引用。与单独使用环状利尿剂相比,添加第二种利尿剂可改善24 h时的负体液平衡[MD: -1.06 L (95%CI: -1.46;-0.65)],由噻嗪类药物联合呋塞米驱动[MD: -1.25 L (95%CI: -1.68;-0.82)],而环利尿剂联合乙酰唑胺组无差异[MD: -0.40 L (95%CI: -0.96;0.16)]或螺内酯[MD: -0.65 L (95%CI: -1.66;0.36)]。异质性很高,临床和安全性终点的报告在不同的研究中有所不同。结论:基于有限的证据,在循环利尿剂的基础上添加第二种利尿剂可能促进呼吸衰竭患者的利尿和负体液平衡,但仅当使用噻嗪类药物时。需要进一步进行更大规模的试验来评估这些干预措施对呼吸衰竭患者的安全性和有效性。
{"title":"Diuretic combinations in critically ill patients with respiratory failure: A systematic review and meta-analysis.","authors":"Jean Maxime Côté,&nbsp;Nadir Goulamhoussen,&nbsp;Blaithin A McMahon,&nbsp;Patrick T Murray","doi":"10.5492/wjccm.v11.i3.178","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.178","url":null,"abstract":"<p><strong>Background: </strong>In patients with respiratory failure, loop diuretics remain the cornerstone of the treatment to maintain fluid balance, but resistance is common.</p><p><strong>Aim: </strong>To determine the efficacy and safety of common diuretic combinations in critically ill patients with respiratory failure.</p><p><strong>Methods: </strong>We searched MEDLINE, Embase, Cochrane Library and PROSPERO for studies reporting the effects of a combination of a loop diuretic with another class of diuretic. A meta-analysis using mean differences (MD) with 95% confidence interval (CI) was performed for the 24-h fluid balance (primary outcome) and the 24-h urine output, while descriptive statistics were used for safety events.</p><p><strong>Results: </strong>Nine studies totalling 440 patients from a total of 6510 citations were included. When compared to loop diuretics alone, the addition of a second diuretic is associated with an improved negative fluid balance at 24 h [MD: -1.06 L (95%CI: -1.46; -0.65)], driven by the combination of a thiazide plus furosemide [MD: -1.25 L (95%CI: -1.68; -0.82)], while no difference was observed with the combination of a loop-diuretic plus acetazolamide [MD: -0.40 L (95%CI: -0.96; 0.16)] or spironolactone [MD: -0.65 L (95%CI: -1.66; 0.36)]. Heterogeneity was high and the report of clinical and safety endpoints varied across studies.</p><p><strong>Conclusion: </strong>Based on limited evidence, the addition of a second diuretic to a loop diuretic may promote diuresis and negative fluid balance in patients with respiratory failure, but only when using a thiazide. Further larger trials to evaluate the safety and efficacy of such interventions in patients with respiratory failure are required.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/80/WJCCM-11-178.PMC9136719.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Stress cardiomyopathy in critical care: A case series of 109 patients. 重症监护中的应激性心肌病:109例患者的病例系列。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.149
Parth Pancholi, Nader Emami, Melissa J Fazzari, Sumit Kapoor

Background: Critically ill patients are at risk of developing stress cardiomyopathy (SC) but can be under-recognized.

Aim: To describe a case series of patients with SC admitted to critical care units.

Methods: We conducted a retrospective observational study at a tertiary care teaching hospital. All adult (≥ 18 years old) patients admitted to the critical care units with stress cardiomyopathy over 5 years were included.

Results: Of 24279 admissions to the critical care units [19139 to medical-surgical intensive care units (MSICUs) and 5140 in coronary care units (CCUs)], 109 patients with SC were identified. Sixty (55%) were admitted to the coronary care units (CCUs) and forty-nine (45%) to the medical-surgical units (MSICUs). The overall incidence of SC was 0.44%, incidence in CCU and MSICU was 1.16% and 0.25% respectively. Sixty-two (57%) had confirmed SC and underwent cardiac catheterization whereas 47 (43%) had clinical SC, and did not undergo cardiac catheterization. Forty-three (72%) patients in the CCUs were diagnosed with primary SC, whereas all (100%) patients in MSICUs developed secondary SC. Acute respiratory failure that required invasive mechanical ventilation and shock developed in twenty-nine (59%) MSICU patients. There were no statistically significant differences in intensive care unit (ICU) mortality, in-hospital mortality, use of inotropic or mechanical circulatory support based on type of unit or anatomical variant.

Conclusion: Stress cardiomyopathy can be under-recognized in the critical care setting. Intensivists should have a high index of suspicion for SC in patients who develop sudden or worsening unexplained hemodynamic instability, arrhythmias or respiratory failure in ICU.

背景:危重患者有发生应激性心肌病(SC)的风险,但可能未被充分认识。目的:描述一系列入住重症监护病房的SC患者的病例。方法:在某三级教学医院进行回顾性观察研究。所有5年以上因应激性心肌病入住重症监护病房的成人(≥18岁)患者均被纳入研究。结果:在24279例重症监护病房(19139例内科外科重症监护病房(MSICUs)和5140例冠状动脉监护病房(CCUs))入院的患者中,109例确诊为SC。60例(55%)入住冠状动脉监护病房(CCUs), 49例(45%)入住内科外科病房(msicu)。SC的总发病率为0.44%,CCU和MSICU的发病率分别为1.16%和0.25%。62例(57%)确诊为SC并接受了心导管插入术,而47例(43%)有临床SC,未接受心导管插入术。43例(72%)ccu患者被诊断为原发性SC,而所有(100%)MSICU患者被诊断为继发性SC。29例(59%)MSICU患者出现急性呼吸衰竭,需要有创机械通气和休克。重症监护病房(ICU)死亡率、住院死亡率、肌力或机械循环支持的使用在单位类型或解剖变异上无统计学显著差异。结论:应激性心肌病在重症监护中可能被低估。重症监护医师应高度怀疑ICU中出现突然或恶化的不明原因血流动力学不稳定、心律失常或呼吸衰竭的SC患者。
{"title":"Stress cardiomyopathy in critical care: A case series of 109 patients.","authors":"Parth Pancholi,&nbsp;Nader Emami,&nbsp;Melissa J Fazzari,&nbsp;Sumit Kapoor","doi":"10.5492/wjccm.v11.i3.149","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.149","url":null,"abstract":"<p><strong>Background: </strong>Critically ill patients are at risk of developing stress cardiomyopathy (SC) but can be under-recognized.</p><p><strong>Aim: </strong>To describe a case series of patients with SC admitted to critical care units.</p><p><strong>Methods: </strong>We conducted a retrospective observational study at a tertiary care teaching hospital. All adult (≥ 18 years old) patients admitted to the critical care units with stress cardiomyopathy over 5 years were included.</p><p><strong>Results: </strong>Of 24279 admissions to the critical care units [19139 to medical-surgical intensive care units (MSICUs) and 5140 in coronary care units (CCUs)], 109 patients with SC were identified. Sixty (55%) were admitted to the coronary care units (CCUs) and forty-nine (45%) to the medical-surgical units (MSICUs). The overall incidence of SC was 0.44%, incidence in CCU and MSICU was 1.16% and 0.25% respectively. Sixty-two (57%) had confirmed SC and underwent cardiac catheterization whereas 47 (43%) had clinical SC, and did not undergo cardiac catheterization. Forty-three (72%) patients in the CCUs were diagnosed with primary SC, whereas all (100%) patients in MSICUs developed secondary SC. Acute respiratory failure that required invasive mechanical ventilation and shock developed in twenty-nine (59%) MSICU patients. There were no statistically significant differences in intensive care unit (ICU) mortality, in-hospital mortality, use of inotropic or mechanical circulatory support based on type of unit or anatomical variant.</p><p><strong>Conclusion: </strong>Stress cardiomyopathy can be under-recognized in the critical care setting. Intensivists should have a high index of suspicion for SC in patients who develop sudden or worsening unexplained hemodynamic instability, arrhythmias or respiratory failure in ICU.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/79/3c/WJCCM-11-149.PMC9136722.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ideal scoring system for acute pancreatitis: Quest for the Holy Grail. 理想的急性胰腺炎评分系统:追求圣杯。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.198
Deven Juneja

Clinical scoring systems are required to predict complications, severity, need for intensive care unit admission, and mortality in patients with acute pancreatitis. Over the years, many scores have been developed, tested, and compared for their efficacy and accuracy. An ideal score should be rapid, reliable, and validated in different patient populations and geographical areas and should not lose relevance over time. A combination of scores or serial monitoring of a single score may increase their efficacy.

需要临床评分系统来预测急性胰腺炎患者的并发症、严重程度、重症监护病房入院需求和死亡率。多年来,人们开发、测试和比较了许多分数的有效性和准确性。理想的评分应该是快速、可靠的,并在不同的患者群体和地理区域中得到验证,并且不应该随着时间的推移而失去相关性。分数的组合或单个分数的连续监测可能会提高它们的功效。
{"title":"Ideal scoring system for acute pancreatitis: Quest for the Holy Grail.","authors":"Deven Juneja","doi":"10.5492/wjccm.v11.i3.198","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.198","url":null,"abstract":"<p><p>Clinical scoring systems are required to predict complications, severity, need for intensive care unit admission, and mortality in patients with acute pancreatitis. Over the years, many scores have been developed, tested, and compared for their efficacy and accuracy. An ideal score should be rapid, reliable, and validated in different patient populations and geographical areas and should not lose relevance over time. A combination of scores or serial monitoring of a single score may increase their efficacy.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/d7/WJCCM-11-198.PMC9136720.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Plasma D-dimer level in early and late-onset neonatal sepsis. 血浆d -二聚体水平与早、晚发型新生儿败血症的关系。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.139
Mohammed Al-Biltagi, Ehab M Hantash, Mohammed Ramadan El-Shanshory, Enayat Aly Badr, Mohamed Zahra, Manar Hany Anwar

Background: Neonatal sepsis is a life-threatening disease. Early diagnosis is essential, but no single marker of infection has been identified. Sepsis activates a coagulation cascade with simultaneous production of the D-dimers due to lysis of fibrin. D-dimer test reflects the activation of the coagulation system.

Aim: To assess the D-dimer plasma level, elaborating its clinicopathological value in neonates with early-onset and late-onset neonatal sepsis.

Methods: The study was a prospective cross-sectional study that included ninety neonates; divided into three groups: Group I: Early-onset sepsis (EOS); Group II: Late-onset sepsis (LOS); and Group III: Control group. We diagnosed neonatal sepsis according to our protocol. C-reactive protein (CRP) and D-dimer assays were compared between EOS and LOS and correlated to the causative microbiological agents.

Results: D-dimer was significantly higher in septic groups with a considerably higher number of cases with positive D-dimer. Neonates with LOS had substantially higher levels of D-dimer than EOS, with no significant differences in CRP. Neonates with LOS had a significantly longer hospitalization duration and higher gram-negative bacteriemia and mortality rates than EOS (P < 0.01). Gram-negative bacteria have the highest D-dimer levels (Acinetobacter, Klebsiella, and Pseudomonas) and CRP (Serratia, Klebsiella, and Pseudomonas); while gram-positive sepsis was associated with relatively lower levels. D-dimer had a significant negative correlation with hemoglobin level and platelet count; and a significant positive correlation with CRP, hospitalization duration, and mortality rates. The best-suggested cut-off point for D-dimer in neonatal sepsis was 0.75 mg/L, giving a sensitivity of 72.7% and specificity of 86.7%. The D-dimer assay has specificity and sensitivity comparable to CRP in the current study.

Conclusion: The current study revealed a significant diagnostic value for D-dimer in neonatal sepsis. D-dimer can be used as an adjunct to other sepsis markers to increase the sensitivity and specificity of diagnosing neonatal sepsis.

背景:新生儿败血症是一种危及生命的疾病。早期诊断至关重要,但尚未发现单一的感染标志。脓毒症激活凝血级联反应,同时由于纤维蛋白的裂解产生d -二聚体。d -二聚体试验反映凝血系统的激活。目的:探讨d -二聚体在新生儿早、晚发型脓毒症中的临床病理意义。方法:本研究为前瞻性横断面研究,纳入90例新生儿;分为三组:第一组:早发性脓毒症(EOS);第二组:迟发性脓毒症(LOS);第三组:对照组。我们根据方案诊断新生儿败血症。c -反应蛋白(CRP)和d -二聚体测定在EOS和LOS之间进行比较,并与致病微生物因子相关。结果:脓毒症组d -二聚体明显增高,且d -二聚体阳性的病例数明显增多。LOS新生儿的d -二聚体水平明显高于EOS, CRP水平无显著差异。LOS患儿住院时间、革兰氏阴性菌血症和死亡率均显著高于EOS患儿(P < 0.01)。革兰氏阴性菌具有最高的d -二聚体水平(不动杆菌、克雷伯氏菌和假单胞菌)和CRP(沙雷氏菌、克雷伯氏菌和假单胞菌);而革兰氏阳性败血症则与相对较低的水平相关。d -二聚体与血红蛋白水平、血小板计数呈显著负相关;与CRP、住院时间、死亡率呈显著正相关。d -二聚体诊断新生儿脓毒症的最佳临界值为0.75 mg/L,敏感性为72.7%,特异性为86.7%。在目前的研究中,d -二聚体检测具有与CRP相当的特异性和敏感性。结论:本研究揭示了d -二聚体在新生儿败血症诊断中的重要价值。d -二聚体可作为其他脓毒症标志物的辅助,提高诊断新生儿脓毒症的敏感性和特异性。
{"title":"Plasma D-dimer level in early and late-onset neonatal sepsis.","authors":"Mohammed Al-Biltagi,&nbsp;Ehab M Hantash,&nbsp;Mohammed Ramadan El-Shanshory,&nbsp;Enayat Aly Badr,&nbsp;Mohamed Zahra,&nbsp;Manar Hany Anwar","doi":"10.5492/wjccm.v11.i3.139","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.139","url":null,"abstract":"<p><strong>Background: </strong>Neonatal sepsis is a life-threatening disease. Early diagnosis is essential, but no single marker of infection has been identified. Sepsis activates a coagulation cascade with simultaneous production of the D-dimers due to lysis of fibrin. D-dimer test reflects the activation of the coagulation system.</p><p><strong>Aim: </strong>To assess the D-dimer plasma level, elaborating its clinicopathological value in neonates with early-onset and late-onset neonatal sepsis.</p><p><strong>Methods: </strong>The study was a prospective cross-sectional study that included ninety neonates; divided into three groups: Group I: Early-onset sepsis (EOS); Group II: Late-onset sepsis (LOS); and Group III: Control group. We diagnosed neonatal sepsis according to our protocol. C-reactive protein (CRP) and D-dimer assays were compared between EOS and LOS and correlated to the causative microbiological agents.</p><p><strong>Results: </strong>D-dimer was significantly higher in septic groups with a considerably higher number of cases with positive D-dimer. Neonates with LOS had substantially higher levels of D-dimer than EOS, with no significant differences in CRP. Neonates with LOS had a significantly longer hospitalization duration and higher gram-negative bacteriemia and mortality rates than EOS (<i>P</i> < 0.01). Gram-negative bacteria have the highest D-dimer levels (Acinetobacter, Klebsiella, and Pseudomonas) and CRP (Serratia, Klebsiella, and Pseudomonas); while gram-positive sepsis was associated with relatively lower levels. D-dimer had a significant negative correlation with hemoglobin level and platelet count; and a significant positive correlation with CRP, hospitalization duration, and mortality rates. The best-suggested cut-off point for D-dimer in neonatal sepsis was 0.75 mg/L, giving a sensitivity of 72.7% and specificity of 86.7%. The D-dimer assay has specificity and sensitivity comparable to CRP in the current study.</p><p><strong>Conclusion: </strong>The current study revealed a significant diagnostic value for D-dimer in neonatal sepsis. D-dimer can be used as an adjunct to other sepsis markers to increase the sensitivity and specificity of diagnosing neonatal sepsis.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f7/c6/WJCCM-11-139.PMC9136721.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Need for oxygen therapy and ventilatory support in premature infants in a hospital in Southern Brazil. 巴西南部一家医院早产儿的氧气治疗和呼吸支持需求。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.160
Amanda Meier, Kelser de Souza Kock

Background: Prematurity in newborns is a condition that is associated with worse hospital outcomes when compared to birth to term. A preterm infant (PI) is classified when gestational age (GA) < 37 wk.

Aim: To analyze prognostic indicators related to the use of oxygen therapy, non-invasive ventilation (continuous positive airway pressure) and mechanical ventilation (MV) in PI.

Methods: This is a retrospective cohort. The sample was composed of PIs from a private hospital in southern Brazil. We included neonates with GA < 37 wk of gestation in the period of January 1, 2018 to December 31, 2018. For data collection, electronic records were used in the Tasy PhilipsTM system, identifying the variables: maternal age, type of birth, prenatal information, GA, Apgar score, birth weight, neonatal morbidities, vital signs in the 1st hour at birth, need for oxygen therapy, continuous positive airway pressure and MV, hospitalization in the neonatal intensive care unit, length of stay and discharge or death.

Results: In total, 90 PI records were analyzed. The median (p25-p75) of GA was 34.0 (31.9-35.4) wk, and there were 45 (50%) males. The most common morbidity among PIs was the acute respiratory discomfort syndrome, requiring hospitalization in the neonatal intensive care unit in 76 (84.4%) cases. The utilization rate of oxygen therapy, continuous positive airway pressure and MV was 12 (13.3%), 37 (41.1%) and 13 (14.4%), respectively. The median (p25-p75) length of stay was 12.0 (5.0-22.2) d, with 10 (11.1%) deaths. A statistical association was observed with the use of MV and GA < 28 wk, lower maternal age, low birth weight, Apgar < 8 and neonatal deaths.

Conclusion: The identification of factors related to the need for MV in prematurity may help in the indication of a qualified team and technologies to promptly meet the unforeseen events that may occur after birth.

背景:与足月儿相比,早产儿的住院预后较差。目的:分析与早产儿使用氧疗、无创通气(持续气道正压)和机械通气(MV)有关的预后指标:这是一项回顾性队列研究。样本由巴西南部一家私立医院的 PI 组成。我们纳入了 2018 年 1 月 1 日至 2018 年 12 月 31 日期间妊娠期 GA 小于 37 周的新生儿。数据收集使用了 Tasy PhilipsTM 系统中的电子记录,确定了以下变量:产妇年龄、分娩类型、产前信息、GA、Apgar 评分、出生体重、新生儿发病率、出生后 1 小时内的生命体征、氧疗需求、持续气道正压和 MV、新生儿重症监护室住院情况、住院时间和出院或死亡:共分析了 90 份 PI 记录。GA的中位数(p25-p75)为34.0(31.9-35.4)周,男性有45人(50%)。新生儿感染中最常见的发病是急性呼吸道不适综合征,76 例(84.4%)需要在新生儿重症监护室住院治疗。氧疗、持续气道正压和 MV 的使用率分别为 12(13.3%)、37(41.1%)和 13(14.4%)。住院时间中位数(p25-p75)为 12.0(5.0-22.2)天,死亡人数为 10(11.1%)人。观察到使用中压和孕期小于28周、产妇年龄较小、出生体重较低、Apgar小于8和新生儿死亡之间存在统计学关联:结论:确定早产儿是否需要使用中压的相关因素,有助于确定合格的团队和技术,及时应对出生后可能发生的意外情况。
{"title":"Need for oxygen therapy and ventilatory support in premature infants in a hospital in Southern Brazil.","authors":"Amanda Meier, Kelser de Souza Kock","doi":"10.5492/wjccm.v11.i3.160","DOIUrl":"10.5492/wjccm.v11.i3.160","url":null,"abstract":"<p><strong>Background: </strong>Prematurity in newborns is a condition that is associated with worse hospital outcomes when compared to birth to term. A preterm infant (PI) is classified when gestational age (GA) < 37 wk.</p><p><strong>Aim: </strong>To analyze prognostic indicators related to the use of oxygen therapy, non-invasive ventilation (continuous positive airway pressure) and mechanical ventilation (MV) in PI.</p><p><strong>Methods: </strong>This is a retrospective cohort. The sample was composed of PIs from a private hospital in southern Brazil. We included neonates with GA < 37 wk of gestation in the period of January 1, 2018 to December 31, 2018. For data collection, electronic records were used in the Tasy Philips<sup>TM</sup> system, identifying the variables: maternal age, type of birth, prenatal information, GA, Apgar score, birth weight, neonatal morbidities, vital signs in the 1st hour at birth, need for oxygen therapy, continuous positive airway pressure and MV, hospitalization in the neonatal intensive care unit, length of stay and discharge or death.</p><p><strong>Results: </strong>In total, 90 PI records were analyzed. The median (p25-p75) of GA was 34.0 (31.9-35.4) wk, and there were 45 (50%) males. The most common morbidity among PIs was the acute respiratory discomfort syndrome, requiring hospitalization in the neonatal intensive care unit in 76 (84.4%) cases. The utilization rate of oxygen therapy, continuous positive airway pressure and MV was 12 (13.3%), 37 (41.1%) and 13 (14.4%), respectively. The median (p25-p75) length of stay was 12.0 (5.0-22.2) d, with 10 (11.1%) deaths. A statistical association was observed with the use of MV and GA < 28 wk, lower maternal age, low birth weight, Apgar < 8 and neonatal deaths.</p><p><strong>Conclusion: </strong>The identification of factors related to the need for MV in prematurity may help in the indication of a qualified team and technologies to promptly meet the unforeseen events that may occur after birth.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b3/1c/WJCCM-11-160.PMC9136723.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40680834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ball-shaped right atrial mass in renal cell carcinoma: A case report 肾细胞癌右心房球形肿块1例
Pub Date : 2022-03-15 DOI: 10.5492/wjccm.v11.i3.192
S. Pothiawala, Savan deSilva, Kunzang Norbu
BACKGROUND Renal cell carcinoma (RCC) is an aggressive tumor, with an incidental discovery in most patients. Classic presentation is rare, and it has a high frequency of local and distant metastasis at the time of detection. CASE SUMMARY We present a rare case of a 58-year-old man with a ball-shaped thrombus in the right atrium at the time of first incidental identification of RCC in the emergency department. Cardiac metastasis, especially thrombus in the right atrium, is rare. It could either be a bland thrombus or a tumor thrombus, and physicians should consider this potentially fatal complication of RCC early at the time of initial presentation. CONCLUSION Ball-shaped lesions in the right atrium are rare, and bland thrombus should be differentiated from tumor thrombus secondary to intracardiac metastasis.
背景肾细胞癌(RCC)是一种侵袭性肿瘤,在大多数患者中偶然发现。经典的表现是罕见的,并且在检测时具有高频率的局部和远处转移。病例摘要:我们报告了一例罕见的病例,一名58岁的男子在急诊科首次偶然发现RCC时,右心房出现球形血栓。心脏转移,特别是右心房血栓,是罕见的。它可能是轻度血栓,也可能是肿瘤血栓,医生应该在初次出现时尽早考虑这种可能致命的RCC并发症。结论右心房球形病变较少见,应将轻度血栓与继发于心内转移的肿瘤血栓区分开来。
{"title":"Ball-shaped right atrial mass in renal cell carcinoma: A case report","authors":"S. Pothiawala, Savan deSilva, Kunzang Norbu","doi":"10.5492/wjccm.v11.i3.192","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.192","url":null,"abstract":"BACKGROUND Renal cell carcinoma (RCC) is an aggressive tumor, with an incidental discovery in most patients. Classic presentation is rare, and it has a high frequency of local and distant metastasis at the time of detection. CASE SUMMARY We present a rare case of a 58-year-old man with a ball-shaped thrombus in the right atrium at the time of first incidental identification of RCC in the emergency department. Cardiac metastasis, especially thrombus in the right atrium, is rare. It could either be a bland thrombus or a tumor thrombus, and physicians should consider this potentially fatal complication of RCC early at the time of initial presentation. CONCLUSION Ball-shaped lesions in the right atrium are rare, and bland thrombus should be differentiated from tumor thrombus secondary to intracardiac metastasis.","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42907047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
世界危重病急救学杂志(英文版)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1